Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Inclusion Criteria : * For subjects aged ≥ 18 years: Informed consent form signed and dated by the subject * For subjects aged \< 18 years: Informed consent form signed and dated by the subject and the subject's parent/legal guardian * Subject (and parent/legal guardian if subject is \< 18 years of age) able to attend the scheduled visit and comply with all trial procedures * For Group 1: Previously received only one dose of meningococcal vaccine (Menactra®, received in Study MTA04, MTA12, MTA19, or MTA21) * For Group 2: Previously received only one dose of meningococcal vaccine (Menomune®, received in Study MTA04) * For Group 3: Aged 14 through 27 years and never received any meningococcal vaccine Exclusion Criteria : * Participation in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure in the 4 weeks preceding inclusion * Known or suspected congenital or acquired immunodeficiency, immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy within the preceding 6 months, or long-term systemic corticosteroids therapy \> 2 weeks * Chronic illness at a stage that could interfere with trial conduct or completion, in the opinion of the investigator * Current alcohol abuse or drug addiction that may interfere with the subject's ability to comply with trial procedures * Receipt of blood or blood-derived products in the past 3 months that might interfere with the assessment of immune responses * Known Human Immunodeficiency Virus (HIV), Hepatitis B, or Hepatitis C seropositivity * History of invasive meningococcal disease (confirmed either clinically, serologically, or microbiologically) * For Groups 1 and 2: Previous vaccination (including booster) against meningococcal disease, with the exception of the Menactra® or Menomune® vaccination received in trial MTA04, MTA12, MTA19, or MTA21 * Subjects deprived of freedom by an administrative or court order, or in an emergency setting, or hospitalized without his/her consent * Received oral or injected antibiotic therapy within the 72 hours prior to the blood draw (temporary criteria)